With knives or branding irons, ancient Greeks would mark criminals or traitors to indicate that they should be shunned and not welcomed in society. The Greeks called that mark a stigma. Today, to stigmatize a person is to classify them by a negative attribute and devalue them on that basis alone. Stigmatizing is a cross-cultural and cross-species...
Read More
In a nutshell This study investigated the safety and effectiveness of semaglutide (Ozempic) in people with type 2 diabetes (T2D). It was determined that semaglutide lowers HbA1c (measures average blood glucose over the last 3 months) without significantly increasing weight gain, hypoglycemia, or gastrointestinal (GI) side effects. Some background...
Read MoreIn a nutshell This is the first study to look at the development of both secondary cancers and cardiovascular disease (CVD) as late side effects of Hodgkin lymphoma (HL) treatment. The study concluded that there was an increased risk of developing both a secondary cancer and CVD in patients treated before 2000. Some background...
Read More
The American Society of Clinical Oncology (ASCO) meets at the beginning of June each year in Chicago. It is the world’s largest oncology organization where researchers from around the world present their research findings. Here are the results of two studies presented during the first couple of days of the conference. Chemotherapy Side Effects and...
Read MoreIn a nutshell This study examined whether newer therapies for non-Hodgkin lymphoma (NHL) were associated with higher odds of negative side effects in older patients. The study concluded that NHL patients over age 65 experienced more serious side effects than younger patients, and these side effects were associated with worse outcomes. Some background...
Read MoreIn a nutshell This study examined whether newer therapies for chronic lymphocytic leukemia (CLL) were associated with higher odds of negative side effects in older patients. The study concluded that CLL patients over age 65 experienced more serious side effects than younger patients. Some background Chronic lymphocytic leukemia (CLL) is commonly...
Read MoreIn a nutshell This paper reviewed the adverse (negative) events associated with new treatments in multiple myeloma. Patients should be closely monitored for adverse events. Some background Multiple myeloma is a cancer of the plasma cells (type of white blood cell). Treatment includes the use of various types of medications. Adverse events...
Read MoreIn a nutshell This study examined whether patients had a higher risk of thromboembolism depending on the chemotherapy drug they received. The study concluded that patients treated with carboplatin had no difference in the risk of thromboembolism compared to patients treating with cisplatin. Some background Chemotherapy is one of the most well-known...
Read More
In a nutshell This study investigated the impact of liposomal doxorubicin (Adriamycin) on cardiac side effects in lymphoma patients compared to conventional doxorubicin. The study suggested that liposomal doxorubicin can reduce cardiac effects and still be an effective therapy, particularly for patients at high risk for anthracycline-induced...
Read More
In a nutshell This study investigated the impact of liposomal doxorubicin (Adriamycin) on cardiac side effects in lymphoma patients compared to conventional doxorubicin. The study suggested that liposomal doxorubicin can reduce cardiac effects and still be an effective therapy, particularly for patients at high risk for anthracycline-induced...
Read More
In a nutshell This study compared side effects between two similar therapies – nilotinib (Tasigna) and dasatinib (Sprycel) – for chronic myeloid leukemia (CML). Researchers reported more serious side effects with dasatinib than with nilotinib. Some background Tyrosine kinase inhibitor (TKI) therapy is a standard first-line treatment...
Read More
In a nutshell This paper reviewed the side effects of drugs used in the treatment of multiple myeloma. Some background Treatment for multiple myeloma includes different groups of medications. Immunomodulatory drugs work by changing the function of the immune systems. Proteasome inhibitors work by blocking the breakdown of proteins that are...
Read More
